Extracorporeal versus peritoneal ultrafiltration in diuretic-resistant congestive heart failure - a review

Medical Science Monitor

Volumn 17, Issue 12, 2011, Pages

  Wańkowicz, Zofia ^a   Próchnicka, Agnieszka ^a   Olszowska, Anna ^a   Baczyński, Daniel ^a   Krzesiński, Paweł ^a   Dziuk, Miroslaw ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Congestive heart failure; Hemodialysis; Isolated ultrafiltration; Peritoneal dialysis; Peritoneal ultrafiltration

Indexed keywords

ICODEXTRIN;

ADRENERGIC SYSTEM; ADULT; CARDIOMEGALY; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; COST; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EXTRACORPOREAL ULTRAFILTRATION; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HUMAN; INTERMETHOD COMPARISON; KIDNEY PERFUSION; MEDLINE; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEAL ULTRAFILTRATION; PHARMACEUTICAL CARE; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; ULTRAFILTRATION;

EID: 82755197270     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882118     Document Type: Review

References (63)

1. Ronco C, Haapio M, House AA et al: Cardiorenal syndrome. J Am Coll Cardiol, 2008; 52: 1527-39
2. Fonarow GC: ADHERE Scientific Advisory Committee, The Acute Decompensated Heart Failure National Registry (ADHERE): opportunites to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med, 2003; 4(Suppl.7): S21-30
3. American Heart Association: Heart disease and stroke statistics: 2005 update. Dallas, TX: American Heart Association, 2005
4. United Nations Economic Commissions for Europe (UNECE). Trends in Europe and North America. The statistical yearbook of the Economic Commission for Europe (Web page). Geneva: UNECE; 2003. [Available at: www.unece.org/stats/trend/trend_h.htm; assesed May 25, 2007
5. Lloyd-Jones D, Adams R, Camethon M et al: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2009; 119: 480-86
6. Korewicki J, Browarek A, Zembala M et al: Polish registry of patients with severe heart failure scheduled for heart transplant POLKARD-HF 2003-2007. Folia Cardiologica Excerpta, 2008; 3: 403-21
7. Hunt SA, Abraham WT, Chin MH et al: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005; 112: e154-e235
8. Jessup M, Brozena S: Heart Failure. N Engl J Med, 2003; 348: 2007-18
9. McMurray JJ, Pfeffer MA: Heart failure. Lancet, 2005; 365(9474): 1877-89
10. Dickstein K, Cohen-Solal A, Filippatos G et al: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008; 29(19): 2388-442
11. Cohn JN: Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation, 1995; 91(10): 2504-7
12. Gheorghiade M, Zannad F, Sopko G et al: Acute heart failure syndromes; current state and framework for future research. Circulation, 2005; 112: 3958-68
13. Wertman BM, Gura V Swarz ER: Ultrafiltration for the Management of Acute Decompensated Heart Failure. J Card Fail, 2008; 9(14): 754-55
14. Gottdiener JS, McClelland RL, Marshall R et al: Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med, 2002; 137: 631-39
15. Jessup M et al: 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Circulation, 2009; 119(14): 1977-2016
16. Moss AJ, Hall WJ, Cannom DS et al: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med, 2009; 361(14): 1329-38
17. Park SJ, Tector A, Piccioni W et al: Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg, 2005; 129(1): 9-17
18. Krishnan A, Oreopoulos DG: Peritoneal dialysis in congestive heart failure. Adv Perit Dial, 2007; 23: 82-89
19. Sanchez JE, Ortega T, Rodriguez C et al: Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant, 2010; 25: 605-10
20. Fiaccadori E, Regolisti G, Maggiore U et al: Ultrafiltration in heart failure. Am Heart J, 2011; 161: 439-49
21. Asaba H, Bergstrom J, Furst P et al: Treatment of diuretic-resistant fluid retention with ultrafiltration. Acta Med Scand, 1978; 204: 145-49
22. Jaski BE, Ha J, Denys BG et al: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail, 2003; 9: 227-31
23. Liang KV, Hiniker AR, Williams AW et al: Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail, 2006; 12: 707-14
24. Bart BA, Boyle A, Bank AJ et al: Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol, 2005; 46: 2043-46
25. Kazory A, Ross EA: Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation, 2008; 117: 975-83
26. Bouman CSC, Van Olden RW, Stoutenbeek CP: Cytokine filtration and adsorption during pre-and postdilution hemofiltration in four different membranes. Blood Purif, 1998; 16(5): 261-68
27. Morgera S, Slowinski T, Melzer C et al: Renal replacement therapy with high-cut-off hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis, 2004; 43(3): 444-453
28. Gambro Internal data-2572-SepteX clearances
29. Haase M, Bellomo R, Baldwin I et al: Hemodialysis Membrane With a High-Molecular-Weight Cutoff and Cytokine levels In Sepsis Complicated by Acute Renal Failure: A Phase 1 Randomized Trial. Am J Kidney Dis, 2007; 50(2): 296-304
30. Costanzo MR, Jessup M: Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis. Heart Fail Rev, 2011
31. Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology, 2001; 96: 132-43
32. Eshaghian S, Horwich TB, Fonarow GC: Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol, 2006; 97: 1759-64
33. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P: Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol, 2005; 46: 2047-51
34. Costanzo MR, Guglin ME, Saltzberg MT et al: UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol, 2007; 49: 675-83
35. Jaski BE, Romeo A, Ortiz B et al: Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration. J Card Fail, 2008; 14: 515-20
36. Rogers HL, Marshall J, Bock J et al: A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail, 2008; 14: 1-5
37. Costanzo MR, Agostoni P, Marenzi G: Extracorporeal fluid removal in heart failure patients. Contrib Nephrol, 2010; 164: 173-98
38. Kazory A, Ejaz AA, Ross EA: Ultrafiltration for heart failure: how fast should we move? Am Heart J, 2009; 157: 205-7
39. Thodis E, Passadakis P, Vargemezis, Oreopoulos PG: Peritoneal dialysis: better than, equal to, or worse than hemodialysis? Perit Dial Int, 2001; 21: 25-35
40. Wańkowicz Z: Peritoneal dialysis-the role in the integrated renal care, pitfalls and benefits of therapy. Advances in Clinical and Experimental Medicine, 2003; 12: 2. http://www.advances.am.wroc.pl
41. Wańkowicz Z: Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease. Pol Arch Int Med, 2009; 119; 810-13
42. Gotloib L, Fudin R, Yakubovich M, Vienken J: Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant, 2005; 20(Suppl.7): vii32-36
43. Ryckelynck JP, Lobbedez T, Valette B et al: Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant, 1998; 13(Suppl.41): 56-59
44. Díez Ojea B, Rodríguez Suárez C, Vidau P et al: Peritoneal dialyisis role in heart failure treatment, experience in our center. Nefrologia, 2007; 27: 605-11
45. Montejo JD, Bajo MA, del Peso G, Selgas R: Role played by peritoneal dialysis in treating refractory heart failure. Nefrologia, 2010; 30: 21-27
46. Cnossen TT, Kooman JP, Konings CJ et al: Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif, 2010; 30: 146-52
47. Nakayama M, Nakano H, Nakayama M: Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiol, 2010; 55: 49-54
48. Takane H, Nakamoto H, Arima H et al: Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure. Adv Perit Dial, 2006; 22: 141-46
49. Wańkowicz Z: Peritoneal dialysis-40 years of own experiences. Pol Arch Int Med, 2004; 112(Spec No): 19-24
50. Prochnicka A, Olszowska A, Baczyński D et al: Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment. Pol Arch Int Med, 2009; 119: 815-18
51. Prochnicka A, Olszowska A, Baczyński D et al: Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment: case report. Pol Arch Int Med, 2009; 119: 834-37
52. Olszowska A, Zelichowski G, Waniewski J et al: The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid. Pol Arch Int Med, 2009; 119: 305-10
53. Horl WH: Natriretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med, 2005; 53: 366-70
54. Zemel D, Imholz AL, de Waart DR et al: Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int, 1994; 46: 1422-30
55. Fincher ME, Campbell HT, Sklar AH et al: Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans. Adv Perit Dial, 1989; 5: 16-19
56. Zoccali C, Mallamaci F, Benedetto FA et al: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol, 2001; 12: 1508-15
57. Chung JH, Yun NR, Ahn CY et al: Relationship between Serum N-Terminal Pro-Brain Natriuretic Peptide Level and Left Ventricular Dysfunction and Extracellular Water in Continuous Ambulatory Peritoneal Dialysis Patients. Electrolyte Blood Press, 2008; 6(1): 15-21
58. Mistry CD, Gokal R, Peers E et al: A randomized multicenter clinical trial comparing isosmolar icodextrin with hypersmolar glucose solutions in CAPD. Kidney Int, 1994; 46: 496-503
59. Basile C, Chimienti D, Bruno A et al: Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int, 2009; 29: 116-18
60. Paniaqua R, Orihuela O, Avila-Diaz M et al: Echocardiographic, electrocardiographic and blood changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int, 2008; 73: 125-30
61. Mehrotra R, Nolph KD, Gotch F: Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int, 1997; 17: 426-30
62. Cappola TP, Felker GM, Kao WH et al: Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation, 2002; 105(14): 1663-68
63. Packer M, Abraham WT, Mehra MR et al: Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol, 2006; 47(11): 2245-52